28 June 2022 | NewsCOVID-19 vaccine booster dose protects against Omicron severe disease, study confirmsRead the full article
A study examining two indoor events in Newcastle, New South Wales at the start of the Omicron outbreak has emphasised the importance of public health and social measures in addition to boosters to maximise protection from the COVID-19 variant of concern.
Associate Professor Bette Liu, the study’s lead author from National Centre for Immunisation Research and Surveillance (NCIRS) and UNSW, Sydney, said while the events were attended by a young population with very high double-vaccination rates, and the findings from these high-risk settings cannot necessarily be translated to other environments, the study provides valuable information supporting the need for public health and social measures to mitigate against transmission.
“Our findings suggest that while recent vaccination with two doses was moderately effective in preventing infection with the Omicron variant, this varies depending on the setting. Social restrictions are needed in high-risk indoor environments, in addition to two doses and a booster, to reduce infection risk,” Associate Professor Liu said.
“At both of the Newcastle indoor entertainment venues, one a nightclub and the other a ball, at least 95 per cent of people had two doses of a COVID-19 vaccine but of those followed-up approximately 55 per cent tested positive.”
Dr Liu said while it was reassuring that none of those infected in the outbreaks were admitted to hospital due to COVID-19, their young age meant the findings could not be compared to the general population.
The outbreaks occurred in environments where social restrictions were absent; there was no mask wearing, nor strict control on density limits, and activities conducive to virus transmission occurred, particularly at the night club with energetic dancing, drinking and close face-to-face contact in mostly small, crowded and poorly ventilated rooms with few external open windows.
Professor David Durrheim, Health Protection Director, Hunter New England Local Health District said the study, as well as data from the UK and South Africa, shows the importance of boosters.
“While we can see moderate protection against hospitalisation for the Omicron variant following two vaccine doses, protection wanes from 2 to 3 months after the second dose but is increased significantly following a booster,” he said.
“Just as important, our study reinforces the need for the public health measures, including wearing masks indoors, on public transport and in schools; density limits; increased ventilation; and restrictions on dancing and singing.
Our study adds to the evidence that these measures and restrictions coupled with recent booster vaccination are the best way to keep our community safe,” Dr Durrheim said.
The study was conducted by researchers from the National Centre for Immunisation Research and Surveillance (NCIRS); Public Health Response Branch, NSW Ministry of Health; Hunter New England Local Health District; University of Newcastle; School of Population Health, UNSW, Sydney; and Faculty of Medicine and Health, University of Sydney.
Read the full report here
Declaration: This report has been released as a pre-print and has not undergone academic peer review; changes may be made before final publication. The authors declare no competing interests.
NCIRS | 0429 350 279 | SCHN-NCIRSMedia@health.nsw.gov.au
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2022 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS